Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-03

COAG vs MAZE: stock comparison and AI forecast

Hemab Therapeutics Holdings, Inc. (COAG) and Maze Therapeutics, Inc. (MAZE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Biological Products, (No Diagnostic Substances)

COAG Hemab Therapeutics Holdings, Inc.

Price
$41.18 +56.6% · 6M
Market Cap
$1.92B
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Biological Products, (No Diagnostic Substances)

MAZE Maze Therapeutics, Inc.

Price
$30.37 +12.8% · 6M
Market Cap
$1.69B
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-21 → 2026-11-03

Six-month price performance

Closing prices rebased to 100 at the start of the window.

90120150180210
COAG +56.6% MAZE +12.8%
COAG · MAZE

Key facts

  • COAG is 1.1 times larger than MAZE by market capitalization ($1.92B against $1.69B).
  • Over the last six months COAG returned +56.6% and MAZE +12.8%.
  • MAZE carries 0.17 times debt per unit of equity, against 0.03 times for COAG.
  • Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricCOAGMAZE
Market Cap$1.92B$1.69B
P/B Ratio4.23x3.72x
EPS–$-1.89
Book Value/Share$9.72$8.16
FCF/Share–$-1.92

Profitability & Margins

MetricCOAGMAZE
ROE–-29.5%
ROA–-25.1%
ROIC–-28.6%
Operating Margin–-364.0%
Net Margin–-334.0%
EBT Margin–-281.7%

Financial Health

MetricCOAGMAZE
Current Ratio35.85x18.31x
D/E Ratio0.03x0.17x
Financial Leverage1.03x1.17x
Working Capital$451M$397M

Cash Flow

MetricCOAGMAZE
Operating Cash Flow–-$107M
Free Cash Flow–-$107M
Capital Spending–-$300K

Income Statement

MetricCOAGMAZE
Operating Income–-$146M
Net Income–-$134M
R&D Expense–$122M

Dividend & Shareholder Information

MetricCOAGMAZE
Shares Outstanding47M56M
FAQ

COAG vs MAZE: stock comparison and AI forecast

Which is bigger, COAG or MAZE?

COAG is 1.1 times larger than MAZE by market capitalization ($1.92B against $1.69B).

Which stock performed better over the last six months, COAG or MAZE?

Over the last six months COAG returned +56.6% and MAZE +12.8%.

Which one does Intratio's AI model rank higher, COAG or MAZE?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.